FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030270 [Registered on: 06/01/2021] Trial Registered Prospectively
Last Modified On: 03/08/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study to evaluate if vitamin deficiency in celiac disease patients can be treated with gluten free diet alone or added vitamin D supplementation is required.  
Scientific Title of Study   Role of supplement in celiac disease patients with vitamin D deficiencies: a randomization control trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jayanta Samanta 
Designation  Assistant Professor 
Affiliation  Post Graduate Institute of Medical Education and Research, Chandigarh 
Address  Faculty Office, Department of Gastroenterology, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  09855319529  
Fax    
Email  dj_samanta@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Jayanta Samanta 
Designation  Assistant Professor 
Affiliation  Post Graduate Institute of Medical Education and Research, Chandigarh 
Address  Faculty Office, Department of Gastroenterology, PGIMER, Chandigarh


CHANDIGARH
160012
India 
Phone  09855319529  
Fax    
Email  dj_samanta@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Sanjay Kumar 
Designation  Research Associate 
Affiliation  Post Graduate Institute of Medical Education and Research, Chandigarh 
Address  Faculty Office, Department of Gastroenterology, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9914377121  
Fax    
Email  sanjay47pgi@gmail.com  
 
Source of Monetary or Material Support  
Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India Sector -12 Chandigarh - 160012 India  
 
Primary Sponsor  
Name  Jayanta Samanta 
Address  Faculty Office, Department of Gastroenterology, PGIMER, Chandigarh 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Jayanta Samanta  Post Graduate Institute of Medical Education and Research, Chandigarh  Faculty Office, Department of Gastroenterology, PGIMER, Chandigarh Sector -12 Chandigarh - 160012
Chandigarh
CHANDIGARH 
9855319529

dj_samanta@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, PGIMER, Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K638||Other specified diseases of intestine,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Gluten free diet and Vitamin D Supplementation  All diagnosed celiac disease patients with Vit D deficiency will be subjected to a gluten-free diet and Vitamin D supplementation (60,000 U weekly for 8 weeks). Pre and post serum IgAtTg, Vitamin D levels will be done at 1 month and 3 months. Various other biochemical parameters and a DEXA scan will also be done  
Comparator Agent  Gluten free diet only  All diagnosed celiac disease patients with Vit D deficiency will be subjected to a gluten-free diet only. Pre and post serum IgAtTg, Vitamin D levels will be done at 1 month and 3 months. Various other biochemical parameters and a DEXA scan will also be done  
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1) Age ≥ 14 years
2) diagnosed case of celiac disease by IgAtTg levels and duodenal biopsy
3) Serum Vitamin D deficiency  
 
ExclusionCriteria 
Details  1) Patients not confirmed to have celiac disease as per clinical/histological/ serological workup.
2) Patients not having Vitamin D deficiency at the time of diagnosis.
3) Patients of celiac disease already on GFD or on Vitamin D supplementation
4) Pregnant females
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Follow up Vitamin D levels


 
At 1 month and 3 months after Vitamin D supplementation


 
 
Secondary Outcome  
Outcome  TimePoints 
DEXA scan, iPTH levels and Quality of life assessment  At 3 months and 6 months  
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/01/2021 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="2"
Days="2" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Celiac disease (CD) is an autoimmune enteropathy predominantly manifesting as a gastrointestinal (GI) tract related disease, triggered by gluten ingestion in the diet. Within the spectrum of its malabsorption syndrome, multiple vitamin deficiencies have been reported in the literature. Vitamin D deficiency gained limelight because of the high incidence of low bone mineral density (BMD) (approximately 50%) reported in earlier literature in patients with CD. Vitamin D deficiency was considered to be one of the main causes of low BMD in such patients. Although the calcitriol form of Vitamin D regulates calcium homeostasis and accounts for the bone mineral dynamics, the majority of the data exists on the detection of the 25 (OH) vitamin D in the sera of the CD patients, present up to a tune of 20.3-59%. Hence the exact implication of the measured vitamin D and the active form in CD is dubious. The correlation between the level of vitamin D and BMD too remains unclear. Data on the effects of vitamin D supplementation in CD patients have also yielded mixed responses, with very few of them actually showing a benefit. Vitamin D might be rather a silent bystander in CD patients, with substantial data to prove that GFD alone can improve BMD levels as well as vitamin D levels in CD patients. This raises the question of the need for supplementation of vitamin D in cases of CD with vitamin D deficiency, which might be advocated otherwise in day-to-day practice as a knee-jerk reaction. No robust data or randomized controlled trial has ever looked into this aspect and hence the current study has been planned. 
Close